A5048530493- Bladder and Urothelial Cancer Treatments
- Pelvic floor disorders treatments
- Urological Disorders and Treatments
- Urinary Tract Infections Management
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- PARP inhibition in cancer therapy
- Enhanced Recovery After Surgery
- Eosinophilic Esophagitis
- Radiomics and Machine Learning in Medical Imaging
- Bone and Joint Diseases
- Cancer Diagnosis and Treatment
- Multiple and Secondary Primary Cancers
- Ureteral procedures and complications
- Bone health and treatments
- Advanced Radiotherapy Techniques
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Cancer, Lipids, and Metabolism
Sanno Medical Center
2024
Shizuoka General Hospital
2022-2023
The objective of this study is to evaluate the need for sterile gloves during cystoscopy by comparing incidence UTI symptoms between patients in whom procedure performed with non-sterile those gloves.
Salvage radical prostatectomy is a postradiation treatment for patients with localized prostate cancer. In 2016, Ozu
Patients with permanent urethral catheterization for chronic urinary retention frequently experience several complications, such as bladder stones and/or tract infections. In this study, we performed vesicostomy in adult patients who developed complications during long-term indwelling catheterization. a catheter retention, and infection between April 2019 October 2021 were enrolled retrospective study. Vesicostomy additional surgeries, vesicolithotomy, if necessary. Residual urine volume was...
Small-cell carcinoma of the prostate has a poor prognosis, and treatment options for refractory disease are unclear.A 68-year-old man with cancer was referred to our hospital. He treated combined androgen blockade (bicalutamide degarelix acetate). The progressed castration-resistant cancer, but additional treatment, prostate-specific antigen levels remained below 0.02 ng/mL. However, computed tomography revealed enlarged right inguinal lymph nodes; moreover, his neuron-specific enolase were...
Castleman's disease is a rare lymphoproliferative disease, mostly found in the mediastinum. The number of cases involving kidneys still limited. We report case primary renal sporadically detected during regular health check-up as pyelonephritis with ureteral stones. In addition, computed tomography showed pelvic and wall thickening paraaortic lymphadenopathy. A lymph node biopsy was performed, but it did not confirm either malignancy or disease. patient underwent open nephroureterectomy for...
Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) is a severe adverse event associated with use bone resorption inhibitors (BRIs), such as zoledronic acid and denosumab. Based on results phase 3 clinical trials for BRIs, frequency ARONJ reported to be 1 2%, but actual could higher. We investigated 173 patients prostate cancer metastases who were treated either or denosumab at our hospital between July 2006 June 2020. occurred in 13 (8%); i.e., ten out 159 (6%) acid, three 14...
Radical cystectomy is an invasive procedure frequently followed by postoperative complications. Although the protocol of enhanced recovery after surgery (ERAS) used in course, several components ERAS may increase workload medical workers. In this study, we added naldemedine tosylate only to routine management instead using and evaluated effect on course robot-assisted radical (RARC). We retrospectively investigated 58 patients who underwent RARC from May 2015 February 2022 at our hospital...
Introduction Patients with nonmetastatic but exceptionally high‐risk prostate cancer are liable to have biochemical failure and may even die. Triple combination therapy, which consists of surgery, radiotherapy, androgen‐deprivation as first‐line treatment, control the disease for a long period. Case presentation We treated patient super‐high‐risk, cancer, triple therapy. He was relapse free at 60 months after initiation treatment. Conclusion therapy be an option cancer.
We report the use of combination chemotherapy gemcitabine (800 mg/m² on day1 and 8) nedaplatin (60 day 1), including neoadjuvant therapy in four cases squamous cell carcinoma urinary tract. In each case, dose was reduced after assessing performance status renal function patient. Among cases, best overall outcome complete response one partial two stable disease case. The main adverse event observed thrombocytopenia; however, no serious events were observed, this regimen safely administered....